Ligand and SQ Innovation Enter into Exclusive Worldwide Captisol License and Supply Agreements for High-Concentration Furosemide Formulation Read more
Priority Review Granted to BeiGene’s Supplemental New Drug Application in China for Tislelizumab in Urothelial Carcinoma Read more
Grifols Announces FDA Approval of Xembify, 20% Subcutaneous Immunoglobulin for Primary Immunodeficiencies Read more
Confo Therapeutics and DyNAbind Announce Drug Discovery Collaboration to Identify Novel GPCR-Modulating Compounds Read more
Roche announces positive results for first global phase III study investigating one-dose Xofluza (baloxavir marboxil) in children with flu Read more
GSK announces phase III start for its anti GM-CSF antibody, otilimab, in patients with rheumatoid arthritis (RA) Read more